Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors.
Trakul N, Chang CN, Harris J, Chapman C, Rao A, Shen J, Quinlan-Davidson S, Filion EJ, Wakelee HA, Colevas AD, Whyte RI, Dieterich S, Maxim PG, Hristov D, Tran P, Le QT, Loo BW Jr, Diehn M. Trakul N, et al. Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):231-7. doi: 10.1016/j.ijrobp.2011.10.071. Epub 2012 Feb 28. Int J Radiat Oncol Biol Phys. 2012. PMID: 22381907
Predictive parameters of CyberKnife fiducial-less (XSight Lung) applicability for treatment of early non-small cell lung cancer: a single-center experience.
Bahig H, Campeau MP, Vu T, Doucet R, Béliveau Nadeau D, Fortin B, Roberge D, Lambert L, Carrier JF, Filion E. Bahig H, et al. Among authors: filion e. Int J Radiat Oncol Biol Phys. 2013 Nov 1;87(3):583-9. doi: 10.1016/j.ijrobp.2013.06.2048. Epub 2013 Aug 14. Int J Radiat Oncol Biol Phys. 2013. PMID: 23953636
Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non-Small-Cell Lung Cancer - Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial.
Swaminath A, Wierzbicki M, Parpia S, Wright JR, Tsakiridis TK, Okawara GS, Kundapur V, Bujold A, Ahmed N, Hirmiz K, Kurien E, Filion E, Gabos Z, Faria S, Louie AV, Owen T, Wai E, Ramchandar K, Chan EK, Julian J, Cline K, Whelan TJ. Swaminath A, et al. Among authors: filion e. Clin Lung Cancer. 2017 Mar;18(2):250-254. doi: 10.1016/j.cllc.2016.08.002. Epub 2016 Oct 3. Clin Lung Cancer. 2017. PMID: 27876603 Clinical Trial.
A dosimetric parameter to limit chest wall toxicity in SABR of NSCLC.
Jumeau R, Filion É, Bahig H, Vu T, Lambert L, Roberge D, Doucet R, Campeau MP. Jumeau R, et al. Among authors: filion e. Br J Radiol. 2017 Jul;90(1075):20170196. doi: 10.1259/bjr.20170196. Epub 2017 Jun 7. Br J Radiol. 2017. PMID: 28590814 Free PMC article.
61 results